Interlace Medical (Framingham, MA) a near commercial-stage gynecological medical device company focused MIS removal of intrauterine fibroids and polyps, closed a $20M Series C financing. Participants include Baird Venture Partners, HLM Venture Partners, Hambrecht & Quist Capital Management, Aperture Venture Partners, New Leaf Venture Partners and Spray Venture Partners.